Thousands to benefit as NHS funds Keytruda lung cancer comboNICE has said MSD’s cancer immunotherapy, Keytruda, should receive interim funding on the NHS in certain patients with Share XThousands to benefit as NHS funds Keytruda lung cancer combohttps://pharmaphorum.com/news/thousands-to-benefit-as-nhs-funds-keytruda-lung-cancer-combo/
